- Trials with a EudraCT protocol (98)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
98 result(s) found for: Transfusion transmitted infections.
Displaying page 1 of 5.
EudraCT Number: 2007-006221-27 | Sponsor Protocol Number: 146/2007/U/Sper | Start Date*: 2008-04-01 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: Immunosuppression without calcineurin inhibitors and with the use of everolimus (Certican) in HCV-infected liver transplant patients | |||||||||||||
Medical condition: HCV cirrhosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004111-37 | Sponsor Protocol Number: BHC-ABT-001 | Start Date*: 2014-10-22 | |||||||||||
Sponsor Name:BUDAI HEPATOLÓGIAI CENTRUM | |||||||||||||
Full Title: Individual Patient Access to AbbVie ABT-450/rítonavir/ABT-267 and ABT 333 Coadministered witb Ribavirín (RBV) in Patient with Genotype 1 Hepatitis C Vírus Infection witb Cirrhosis | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000945-19 | Sponsor Protocol Number: GS-US-248-0122 | Start Date*: 2011-11-21 | ||||||||||||||||
Sponsor Name:Gilead Sciences, Inc. | ||||||||||||||||||
Full Title: A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection | ||||||||||||||||||
Medical condition: Hepatitis C Virus Infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) GB (Prematurely Ended) FR (Prematurely Ended) CZ (Prematurely Ended) HU (Prematurely Ended) PL (Prematurely Ended) IT (Prematurely Ended) AT (Prematurely Ended) SE (Completed) ES (Prematurely Ended) EE (Prematurely Ended) NL (Prematurely Ended) BE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-000946-39 | Sponsor Protocol Number: GS-US-248-0123 | Start Date*: 2011-11-21 | ||||||||||||||||
Sponsor Name:Gilead Sciences, Inc. | ||||||||||||||||||
Full Title: A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection | ||||||||||||||||||
Medical condition: Hepatitis C Virus Infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) GB (Completed) FR (Completed) CZ (Completed) HU (Prematurely Ended) PL (Completed) IT (Completed) AT (Completed) SE (Completed) ES (Completed) EE (Completed) NL (Completed) BE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-002008-28 | Sponsor Protocol Number: 2017-002008-28 | Start Date*: 2017-12-21 | |||||||||||
Sponsor Name:Region Skåne | |||||||||||||
Full Title: A prospective open label study to evaluate treatment of chronic HCV infection with glecaprevir/pibrentasvir in PWID attending a needle exchange program | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002069-77 | Sponsor Protocol Number: RG101-05 | Start Date*: 2016-12-01 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Regulus Therapeutics Inc. | ||||||||||||||||||||||||||||||||||||||
Full Title: An Observational Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Have Previously Received RG-101 | ||||||||||||||||||||||||||||||||||||||
Medical condition: Hepatitis C Patients | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: GR (Completed) HU (Completed) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000416-25 | Sponsor Protocol Number: TMC435-TiDP16-C213 | Start Date*: 2011-09-02 | |||||||||||
Sponsor Name:Janssen R&D Ireland | |||||||||||||
Full Title: A Phase III, open-label trial of TMC435 in combination with peginterferon alpha-2a and ribavirin for HCV genotype-1 infected subjects who participated in the placebo group of a Phase II/III TMC435 ... | |||||||||||||
Medical condition: Hepatitis C Virus (HCV) genotype-1 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) ES (Completed) AT (Completed) PT (Completed) NL (Completed) DE (Completed) PL (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002169-21 | Sponsor Protocol Number: MK5172-047 | Start Date*: 2013-09-11 | ||||||||||||||||
Sponsor Name:Merck Sharp & Dohme Corp. | ||||||||||||||||||
Full Title: A Phase II Clinical Trial to Evaluate the Efficacy and Safety of a Combination Regimen of MK-5172 with/without MK-8742 and/or Ribavirin (RBV) in Treatment-naive Subjects with Chronic Hepatitis C Ge... | ||||||||||||||||||
Medical condition: Hepatitis C Virus Genotype 2, 4, 5 and 6 | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) ES (Completed) BE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-000456-42 | Sponsor Protocol Number: GS-US-256-0148 | Start Date*: 2011-10-04 | ||||||||||||||||
Sponsor Name:Gilead Sciences Inc. | ||||||||||||||||||
Full Title: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Response Guided Therapy with GS 5885 Alone or in Combination with GS-9451 with Peginterferon Alfa 2a and Ribavirin in Treat... | ||||||||||||||||||
Medical condition: Genotype 1 Hepatitis C Virus Infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) GB (Completed) CZ (Completed) HU (Completed) BG (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-001942-16 | Sponsor Protocol Number: GS-US-334-0133 | Start Date*: 2012-08-10 | ||||||||||||||||
Sponsor Name:Gilead Sciences Inc. | ||||||||||||||||||
Full Title: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Investigate the Efficacy and Safety of GS-7977 + Ribavirin for 12 Weeks in Treatment-Naïve and Treatment-Experienced Su... | ||||||||||||||||||
Medical condition: Chronic Genotype 2 or 3 HCV Infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: EE (Completed) AT (Completed) NL (Completed) DE (Completed) GB (Completed) SE (Completed) ES (Completed) PL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-000637-39 | Sponsor Protocol Number: P7977-2025 | Start Date*: 2012-05-17 | ||||||||||||||||
Sponsor Name:Gilead Sciences Inc. | ||||||||||||||||||
Full Title: An Open-Label Study to Explore the Clinical Efficacy of GS-7977 with Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant | ||||||||||||||||||
Medical condition: Hepatitis C Virus (HCV) infection (all genotypes) in patients who have been placed on a wait list for liver transplantation from a deceased doner for hepatocellular carcinoma (HCC). | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-000944-43 | Sponsor Protocol Number: GS-US-248-0120 | Start Date*: 2011-08-09 | ||||||||||||||||
Sponsor Name:Gilead Sciences Inc. | ||||||||||||||||||
Full Title: A Phase 2 Randomized, Open-Label Study of GS-5885 Administered Concomitantly with GS-9451, Tegobuvir and Ribavirin (RBV) to Treatment-Naive Subjects with Chronic Genotype 1 HCV Infection | ||||||||||||||||||
Medical condition: Genotype 1 Hepatitis C Virus Infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-002748-28 | Sponsor Protocol Number: GS-US-248-0131 | Start Date*: 2011-11-30 | ||||||||||||||||
Sponsor Name:Gilead Sciences Inc. | ||||||||||||||||||
Full Title: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) Compared with GS-5885, GS-9451 with Tegobuvir or RBV in Treatment-Experienced Subject... | ||||||||||||||||||
Medical condition: Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-001249-26 | Sponsor Protocol Number: GS-US-337-1431 | Start Date*: 2016-02-12 | ||||||||||||||||
Sponsor Name:Gilead Sciences, Inc. | ||||||||||||||||||
Full Title: A Registry for Subjects with Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment with a Sofosbuvir-Based Regimen without Interferon for Chronic Hepatitis C Infection in Gilead-... | ||||||||||||||||||
Medical condition: Hepatitis C Virus Infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) ES (Completed) GB (GB - no longer in EU/EEA) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-000571-16 | Sponsor Protocol Number: GS-US-334-0109 | Start Date*: 2012-09-21 | ||||||||||||||||
Sponsor Name:Gilead Sciences Inc. | ||||||||||||||||||
Full Title: An Open-Label Study of GS-7977+ Ribavirin for 12 Weeks in Subjects with Chronic HCV Infection who Participated in Prior Studies Evaluating GS-7977. | ||||||||||||||||||
Medical condition: Chronic Genotype 2 or 3 HCV Infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) GB (Completed) SE (Completed) EE (Completed) DE (Completed) NL (Completed) ES (Completed) PL (Completed) CZ (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-005808-14 | Sponsor Protocol Number: TMC435HPC1002 | Start Date*: 2012-03-06 | |||||||||||
Sponsor Name:Janssen R&D Ireland | |||||||||||||
Full Title: A Phase I, open-label, randomized, 3-panel, 3-way crossover trial in healthy adult subjects to assess the relative bioavailability of TMC435 following administration of 2 liquid formulations or 2 d... | |||||||||||||
Medical condition: Hepatitis C Virus (HCV) genotype-1 Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004138-41 | Sponsor Protocol Number: TEL-PR | Start Date*: 2012-12-10 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI PARMA | |||||||||||||
Full Title: Anti-viral T cell responses in patients with chronic HCV infection treated with telaprevir: can therapy induce functional T cell reconstitution? | |||||||||||||
Medical condition: Chronic active hepatitis C never treated previously with anti-HCV therapies | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002608-19 | Sponsor Protocol Number: 64294178HPC3001 | Start Date*: 2017-06-29 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Prospective 3-Year Follow-up Study in Subjects Treated in a Preceding Phase 2 or 3 Study With a Regimen Containing Odalasvir and AL-335 With or Without Simeprevir for the Treatment of Hepatitis C... | |||||||||||||
Medical condition: Chronic Hepatitis C virus infection. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DE (Completed) PL (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003446-27 | Sponsor Protocol Number: TMC435HPC3021 | Start Date*: 2015-01-02 | |||||||||||
Sponsor Name:Janssen R&D Ireland | |||||||||||||
Full Title: A Phase 3, Multicenter, Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of a 12-Week Regimen of Simeprevir in Combination with Sofosbuvir in Treatment-Naïve or -Experienced Subj... | |||||||||||||
Medical condition: Hepatitis C-Infection genotype 4 Patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002459-33 | Sponsor Protocol Number: MEN_BOC | Start Date*: 2011-12-06 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA POLICLINICO DI MODENA | |||||||||||||
Full Title: Boceprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Difficult-to-Treat Menopausal Women With Chronic Hepatitis C Genotype 1, either deemed Nonresponders to Peginterferon/Ribavirin... | |||||||||||||
Medical condition: menopausal women with chronic HCV genotype1, naive or previously treated her with standard antiviral therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
